A Study of Lenalidomide and CC-486 With Radiation Therapy in Patients With Plasmacytoma
Status:
Recruiting
Trial end date:
2021-11-19
Target enrollment:
Participant gender:
Summary
The purpose of this study is to investigate if the combination of CC-486 with lenalidomide
and radiation therapy is a safe and effective treatment for plasmacytoma.